Testing effectiveness (Phase 2)Ended earlyNCT01205334
What this trial is testing
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
Who this might be right for
Glioblastoma MultiformeGBMBrain Cancer
Baylor College of Medicine 2